Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Leukemia

Free Subscription 01.07.2019 1 Am J Hematol 3 Ann Hematol 1 BMC Cancer 1 J Biol Chem 1 J Clin Oncol 1 J Pediatr Hematol Oncol 4 Leuk Lymphoma 4 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Hematol

1. YALNIZ F, Abou Dalle I, Kantarjian H, Borthakur G, et al
   Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib.
   Am J Hematol. 2019 Jun 10. doi: 10.1002/ajh.25553.
   PubMed     Text format     Abstract available
   
   

   
   Ann Hematol

2. RODRIGUEZ-VEIGA R, Montesinos P, Boluda B, Lorenzo I, et al
   Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
   Ann Hematol. 2019 Jun 25. pii: 10.1007/s00277-019-03744.
   PubMed     Text format     Abstract available
   
   
3. KAWASHIMA I, Kumagai T, Suzuki M, Suzuki J, et al
   Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation.
   Ann Hematol. 2019 Jun 25. pii: 10.1007/s00277-019-03733.
   PubMed     Text format    
   
   
4. REYES-LEON A, Ramirez-Martinez M, Fernandez-Garcia D, Amaro-Munoz D, et al
   Variants in ARID5B gene are associated with the development of acute lymphoblastic leukemia in Mexican children.
   Ann Hematol. 2019 Jun 21. pii: 10.1007/s00277-019-03730.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

5. HUANG HH, Chen FY, Chou WC, Hou HA, et al
   Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
   BMC Cancer. 2019;19:617.
   PubMed     Text format     Abstract available
   
   

   
   J Biol Chem

6. ZHANG X, Tu H, Yang Y, Jiang X, et al
   Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway.
   J Biol Chem. 2019 Jun 24. pii: RA119.008037. doi: 10.1074/jbc.RA119.008037.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Oncol

7. RUBNITZ JE, Lacayo NJ, Inaba H, Heym K, et al
   Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial.
   J Clin Oncol. 2019 Jun 27:JCO1900327. doi: 10.1200/JCO.19.00327.
   PubMed     Text format     Abstract available
   
   

   
   J Pediatr Hematol Oncol

8. JOSHI J, Tanner L, Gilchrist L, Bostrom B, et al
   Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia.
   J Pediatr Hematol Oncol. 2019 Jun 21. doi: 10.1097/MPH.0000000000001529.
   PubMed     Text format     Abstract available
   
   

   
   Leuk Lymphoma

9. ROSSOFF J, Platanias LC
   Impact of myosteatosis in survivors of childhood acute lymphoblastic leukemia.
   Leuk Lymphoma. 2019 Jun 21:1-2. doi: 10.1080/10428194.2019.1630623.
   PubMed     Text format    
   
   
10. TATE C, Burgess M, McMillan NA, Saunders NA, et al
    High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy.
    Leuk Lymphoma. 2019 Jun 25:1-5. doi: 10.1080/10428194.2019.1581936.
    PubMed     Text format    
    
    
11. ISHDORJ G, Beiggi S, Nugent Z, Streu E, et al
    Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival.
    Leuk Lymphoma. 2019 Jun 25:1-10. doi: 10.1080/10428194.2019.1620941.
    PubMed     Text format     Abstract available
    
    
12. CHOE HK, van Besien K
    Donor graft genotypes versus leukemia.
    Leuk Lymphoma. 2019;60:1606-1607.
    PubMed     Text format    
    
    

    
    Oncol Rep

13. SAKURAI N, Komada Y, Hanaki R, Morimoto M, et al
    Role of microRNAs in glucocorticoidresistant Bcell precursor acute lymphoblastic leukemia.
    Oncol Rep. 2019 Jun 10. doi: 10.3892/or.2019.7191.
    PubMed     Text format     Abstract available
    
    
14. LIU C, Li Y, Hu R, Han W, et al
    Knockdown of ribonucleotide reductase regulatory subunit M2 increases the drug sensitivity of chronic myeloid leukemia to imatinibbased therapy.
    Oncol Rep. 2019 Jun 11. doi: 10.3892/or.2019.7194.
    PubMed     Text format     Abstract available
    
    
15. BRIGHT SA, Byrne AJ, Vandenberghe E, Browne PV, et al
    Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers.
    Oncol Rep. 2019;41:3127-3136.
    PubMed     Text format     Abstract available
    
    
16. YANG Y, Dai W, Sun Y, Zhao Z, et al
    Long noncoding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
    Oncol Rep. 2019;41:2311-2320.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

17. WOO YM, Kim S, Park JH, Lee NY, et al
    Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation.
    PLoS One. 2019;14:e0218968.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: